FDA Approvals

Medicare Coverage of Alzheimer’s Drugs Relies on FDA Traditional Approval

June 5, 2023 - The Centers for Medicare and Medicaid Services (CMS) has announced that it will provide Medicare coverage for new Alzheimer’s drugs if they receive traditional approval from the Food and Drug Administration (FDA). “Alzheimer’s disease takes a toll on not just the people suffering from the disease but also on their loved ones and...


More Articles